The impact of the modified Atkins diet on lipid profiles in adults with epilepsy

Nutr Neurosci. 2016;19(3):131-7. doi: 10.1179/1476830514Y.0000000162. Epub 2014 Nov 10.

Abstract

Objectives: The modified Atkins diet (MAD) is a high fat, low carbohydrate ketogenic diet used to treat intractable seizures in children and adults. The long-term impact on fasting lipid profiles (FLPs) remains unknown. This study was designed to detect significant lipid changes in adults on MAD.

Methods: Patients were observed prospectively. A FLP was obtained in all patients at the first visit then serially. Patients were started on a 20 g per day net carbohydrate limit MAD. They were screened for risk for coronary heart disease and counseled to reduce saturated fats by a registered dietitian if deemed at risk. Patients that remained on MAD for 3 or more months with one or more follow-up FLP were included.

Results: Thirty-seven patients (14 male), mean age 33 years (SD 13, range 18-59) met study criteria. Median diet duration was 16 months (range 3-41). Total cholesterol and low-density lipoprotein (LDL) increased significantly over the first 3 months of MAD (P = 0.01 and 0.008, respectively), but were not significantly different from baseline after 1 year of treatment (P = 0.2 and P = 0.5, respectively). High-density lipoprotein levels trended upward in the first 3 months (P = 0.05) and triglycerides remained unchanged (P = 0.5). In 12 patients followed for 3 or more years, no cardiovascular or cerebrovascular events were reported.

Discussion: Although total cholesterol and LDL increased over the first 3 months of the MAD, these values normalized within a year of treatment, including in patients treated with MAD for more than 3 years.

Keywords: Cholesterol; Epilepsy; Hyperlipidemia; Ketogenic diet; Lipoprotein; Modified Atkins diet; Seizure; Triglycerides.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Baltimore / epidemiology
  • Biomarkers / blood
  • Biomarkers / urine
  • Cholesterol / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / etiology*
  • Coronary Disease / prevention & control
  • Diet, Ketogenic / adverse effects*
  • Dietary Fats, Unsaturated / therapeutic use*
  • Epilepsy / blood
  • Epilepsy / diet therapy*
  • Epilepsy / urine
  • Female
  • Humans
  • Hypercholesterolemia / epidemiology
  • Hypercholesterolemia / etiology*
  • Hypercholesterolemia / physiopathology
  • Hypercholesterolemia / prevention & control
  • Ketones / urine
  • Lipoproteins, LDL / blood
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Patient Compliance
  • Patient Education as Topic
  • Prospective Studies
  • Risk Factors
  • Young Adult

Substances

  • Biomarkers
  • Dietary Fats, Unsaturated
  • Ketones
  • Lipoproteins, LDL
  • Cholesterol